{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:47:29Z","timestamp":1789055249635,"version":"build-2803163510"},"reference-count":47,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Infections due to Carbapenem-resistant\n                      <jats:italic toggle=\"yes\">Acinetobacter baumannii<\/jats:italic>\n                      (CRAB) are a significant burden and are associated with devastating outcomes. Subsequently, CRAB is recognized as an urgent threat to human health by the United States (US) Centers for Disease Control and Prevention and is designated a critical pathogen, with the highest priority for research and development of novel treatment options, by the World Health Organization. Sulbactam-durlobactam was approved by the US Food and Drug Administration in 2023 for the treatment of Hospital Acquired and Ventilator Associated Bacterial Pneumonia caused by susceptible strains of\n                      <jats:italic toggle=\"yes\">A. baumannii<\/jats:italic>\n                      , and as of 2024, is the Infectious Diseases Society of America Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections preferred treatment strategy, in combination with a carbapenem, for infections due to CRAB. In this commentary, we will dive into the preclinical and clinical evidence supporting this approval. We will further explore controversial and emerging questions related to sulbactam-durlobactam, including the necessity of carbapenem combination therapy for CRAB and the other potential therapeutic opportunities durlobactam may provide beyond\n                      <jats:italic toggle=\"yes\">A. baumannii<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/aac.01086-24","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T14:24:34Z","timestamp":1755872674000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":12,"title":["New Perspectives on Antimicrobial Agents: Sulbactam-durlobactam"],"prefix":"10.1128","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4780-6215","authenticated-orcid":true,"given":"Jason M.","family":"Pogue","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00jmfr291","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Pharmacy, University of Michigan College of Pharmacy","place":["Ann Arbor, USA"]},{"id":[{"id":"https:\/\/ror.org\/01zcpa714","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pharmacy, University of Michigan Health","place":["Ann Arbor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Harrington","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00jmfr291","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Pharmacy, University of Michigan College of Pharmacy","place":["Ann Arbor, USA"]},{"id":[{"id":"https:\/\/ror.org\/01zcpa714","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pharmacy, University of Michigan Health","place":["Ann Arbor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaiporn","family":"Wangchinda","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01znkr924","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medicine Siriraj Hospital, Mahidol University","place":["Bangkok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith S.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology and Infectious Diseases, Rutgers Robert Wood Johnson Medical School","place":["New Brunswick, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00058-16"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01975-21"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000125"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12363"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy293"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_1_8_2","unstructured":"Centers for Disease Control and Prevention. 2019. Antibiotic resistance threats in the United States 2019. Atlanta GA U.S. Department of Health and Human Services"},{"key":"e_1_3_1_9_2","unstructured":"World Health Organization. 2017. Prioritization of pathogens to guide discovery research and development of new antibiotics for drug-resistant bacterial infections including tuberculosis. Geneva Switzerland World Health Organization"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04808-14"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.11.025"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00541-4"},{"key":"e_1_3_1_14_2","unstructured":"SENTRY Antimicrobial Surveillance Program. 2025. JMI Laboratories. Available from: https:\/\/sentry-mvp.jmilabs.com"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2024.01.019"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.02.012"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae218"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.05.018"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.104"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01698-23"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00781-22"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa208"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2022.05.011"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02534-19"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad556"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11121793"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00665-23"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00184-6"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30796-9"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30731-3"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30747-8"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30403-7"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01627-24"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00312-23"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00800-23"},{"key":"e_1_3_1_36_2","unstructured":"U.S. Food and Drug Administration. 2023. FDA briefing document: NDA 216974 Drug Name: Sulbactam-durlobactam for injection. Applicant: Entasis Therapeutics Inc. Antimicrobial Drugs Advisory Committee Meeting"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01089-18"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac492.1896"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00485-24"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106776"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad276"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2024.10.012"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae229"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04819-14"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad061"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae140"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00440-23"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01543-24"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01086-24","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01086-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:01:36Z","timestamp":1759323696000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01086-24"}},"subtitle":[],"editor":[{"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1128\/aac.01086-24"],"URL":"https:\/\/doi.org\/10.1128\/aac.01086-24","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-08-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01086-24"}}